학술논문
Ibrutinib Treatment Improves T-Cell Proliferative Ability and Effector Function in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Patients
Document Type
Abstract
Author
Source
In Blood 29 November 2018 132 Supplement 1:3114-3114
Subject
Language
ISSN
0006-4971